strain_accession,species_name,species_id,gene_name,card_accession,mechanism,AMR_gene_ref_strain,card_drug_class,definition,amr_seqid,contig,strand,position,coverage,identity,host,source,source_detail,country,date,MLST,subspecies_id,subspecies_name
ERR330830,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR330830_AMRSEG0001,NODE_4_length_547095_cov_26.958512,positive,95294-98709,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,37.0,,
ERR330830,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR330830_AMRSEG0002,NODE_4_length_547095_cov_26.958512,positive,371148-371834,100.0,85.3,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,37.0,,
ERR330830,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR330830_AMRSEG0003,NODE_8_length_269571_cov_26.969129,negative,240941-241259,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,37.0,,
ERR330831,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR330831_AMRSEG0001,NODE_2_length_783032_cov_22.215097,negative,48089-51504,97.25,80.88,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,,,
ERR330831,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR330831_AMRSEG0002,NODE_6_length_311187_cov_18.318706,negative,249934-250252,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,,,
ERR330831,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR330831_AMRSEG0003,NODE_7_length_277606_cov_18.793603,negative,42248-42934,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,,,
ERR330832,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR330832_AMRSEG0001,NODE_2_length_783032_cov_30.862830,positive,731529-734944,97.25,80.88,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,441.0,,
ERR330832,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR330832_AMRSEG0002,NODE_6_length_311187_cov_30.607430,negative,249934-250252,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,441.0,,
ERR330832,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR330832_AMRSEG0003,NODE_7_length_290421_cov_32.512478,positive,247488-248174,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,441.0,,
ERR330833,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR330833_AMRSEG0001,NODE_1_length_918796_cov_27.582156,positive,488669-492084,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,440.0,,
ERR330833,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR330833_AMRSEG0002,NODE_1_length_918796_cov_27.582156,positive,766074-766760,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,440.0,,
ERR330833,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR330833_AMRSEG0003,NODE_9_length_216321_cov_26.682962,positive,27847-28165,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/8/27,440.0,,
ERR337745,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR337745_AMRSEG0001,NODE_1_length_969909_cov_29.304045,positive,484109-487524,97.25,80.88,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/9/3,,,
ERR337745,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR337745_AMRSEG0002,NODE_1_length_969909_cov_29.304045,positive,767582-768268,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/9/3,,,
ERR337745,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR337745_AMRSEG0003,NODE_5_length_639926_cov_29.057009,positive,60922-61240,92.46,83.39,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/9/3,,,
ERR337757,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR337757_AMRSEG0001,NODE_1_length_1003203_cov_27.036543,positive,678647-682062,97.25,80.88,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/9/3,441.0,,
ERR337757,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR337757_AMRSEG0002,NODE_1_length_1003203_cov_27.036543,positive,960270-960956,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/9/3,441.0,,
ERR337757,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR337757_AMRSEG0003,NODE_7_length_311187_cov_26.936472,negative,249934-250252,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/9/3,441.0,,
ERR337764,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR337764_AMRSEG0001,NODE_2_length_660072_cov_28.270411,positive,95303-98718,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/9/3,37.0,,
ERR337764,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR337764_AMRSEG0002,NODE_2_length_660072_cov_28.270411,positive,371157-371843,100.0,85.3,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/9/3,37.0,,
ERR337764,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR337764_AMRSEG0003,NODE_8_length_279327_cov_27.837222,negative,250697-251015,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/9/3,37.0,,
ERR363317,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR363317_AMRSEG0001,NODE_2_length_783141_cov_22.708240,negative,48089-51504,97.25,80.88,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,441.0,,
ERR363317,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR363317_AMRSEG0002,NODE_6_length_311187_cov_18.688963,negative,249934-250252,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,441.0,,
ERR363317,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR363317_AMRSEG0003,NODE_7_length_277606_cov_19.246229,positive,234673-235359,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,441.0,,
ERR363318,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR363318_AMRSEG0001,NODE_2_length_783116_cov_10.255555,positive,731613-735028,97.25,80.88,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,441.0,,
ERR363318,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR363318_AMRSEG0002,NODE_5_length_311187_cov_10.208917,negative,249934-250252,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,441.0,,
ERR363318,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR363318_AMRSEG0003,NODE_6_length_290421_cov_10.882190,positive,247488-248174,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,441.0,,
ERR363319,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR363319_AMRSEG0001,NODE_10_length_215355_cov_17.180615,negative,188157-188475,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,440.0,,
ERR363319,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR363319_AMRSEG0002,NODE_1_length_919031_cov_17.861385,negative,152037-152723,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,440.0,,
ERR363319,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR363319_AMRSEG0003,NODE_1_length_919031_cov_17.861385,negative,426713-430128,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,440.0,,
ERR363322,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR363322_AMRSEG0001,NODE_1_length_829072_cov_34.728619,negative,26072-26758,100.0,85.3,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,704.0,,
ERR363322,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR363322_AMRSEG0002,NODE_1_length_829072_cov_34.728619,negative,320029-323444,97.25,80.77,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,704.0,,
ERR363322,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR363322_AMRSEG0003,NODE_4_length_458869_cov_33.010083,negative,402948-403266,92.46,83.07,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,704.0,,
ERR363326,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR363326_AMRSEG0001,NODE_1_length_829162_cov_35.974770,negative,26072-26758,100.0,85.3,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,704.0,,
ERR363326,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR363326_AMRSEG0002,NODE_1_length_829162_cov_35.974770,negative,320029-323444,97.25,80.77,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,704.0,,
ERR363326,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR363326_AMRSEG0003,NODE_5_length_458869_cov_34.088244,negative,402948-403266,92.46,83.07,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,704.0,,
ERR363327,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR363327_AMRSEG0001,NODE_1_length_1571319_cov_34.043771,positive,1029819-1033234,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,37.0,,
ERR363327,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR363327_AMRSEG0002,NODE_1_length_1571319_cov_34.043771,positive,1307203-1307889,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,37.0,,
ERR363327,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR363327_AMRSEG0003,NODE_6_length_216319_cov_31.597491,negative,188155-188473,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,37.0,,
ERR363328,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR363328_AMRSEG0001,NODE_1_length_829142_cov_37.642806,negative,26072-26758,100.0,85.3,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,704.0,,
ERR363328,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR363328_AMRSEG0002,NODE_1_length_829142_cov_37.642806,negative,320029-323444,97.25,80.77,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,704.0,,
ERR363328,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR363328_AMRSEG0003,NODE_4_length_458869_cov_35.987910,positive,55604-55922,92.46,83.07,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,704.0,,
ERR363335,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR363335_AMRSEG0001,NODE_1_length_969909_cov_30.405374,negative,201642-202328,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,444.0,,
ERR363335,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR363335_AMRSEG0002,NODE_1_length_969909_cov_30.405374,negative,482386-485801,97.25,80.88,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,444.0,,
ERR363335,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR363335_AMRSEG0003,NODE_5_length_639926_cov_30.214224,negative,578687-579005,92.46,83.39,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,444.0,,
ERR363347,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR363347_AMRSEG0001,NODE_2_length_767315_cov_32.312981,negative,42248-42934,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,441.0,,
ERR363347,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR363347_AMRSEG0002,NODE_2_length_767315_cov_32.312981,negative,321142-324557,97.25,80.88,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,441.0,,
ERR363347,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR363347_AMRSEG0003,NODE_7_length_311187_cov_32.316707,negative,249934-250252,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,441.0,,
ERR363354,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR363354_AMRSEG0001,NODE_2_length_660072_cov_32.747179,positive,95303-98718,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,37.0,,
ERR363354,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR363354_AMRSEG0002,NODE_2_length_660072_cov_32.747179,positive,371157-371843,100.0,85.3,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,37.0,,
ERR363354,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR363354_AMRSEG0003,NODE_8_length_305323_cov_32.487538,positive,54309-54627,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2013/11/4,37.0,,
ERR459750,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR459750_AMRSEG0001,NODE_3_length_526392_cov_21.080136,negative,152035-152721,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459750,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR459750_AMRSEG0002,NODE_3_length_526392_cov_21.080136,negative,426710-430125,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459750,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR459750_AMRSEG0003,NODE_7_length_277842_cov_18.622167,positive,28314-28632,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459751,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR459751_AMRSEG0001,NODE_2_length_921187_cov_32.998250,positive,491060-494475,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459751,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR459751_AMRSEG0002,NODE_2_length_921187_cov_32.998250,positive,768465-769151,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459751,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR459751_AMRSEG0003,NODE_9_length_215354_cov_31.145190,positive,26881-27199,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459753,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR459753_AMRSEG0001,NODE_1_length_1003203_cov_28.747965,positive,678647-682062,97.25,80.88,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,441.0,,
ERR459753,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR459753_AMRSEG0002,NODE_1_length_1003203_cov_28.747965,positive,960270-960956,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,441.0,,
ERR459753,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR459753_AMRSEG0003,NODE_7_length_311187_cov_27.546785,negative,249934-250252,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,441.0,,
ERR459754,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR459754_AMRSEG0001,NODE_2_length_525478_cov_28.187153,negative,152037-152723,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459754,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR459754_AMRSEG0002,NODE_2_length_525478_cov_28.187153,negative,426719-430134,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459754,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR459754_AMRSEG0003,NODE_8_length_277798_cov_26.863769,negative,250600-250918,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459755,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR459755_AMRSEG0001,NODE_10_length_215354_cov_25.545411,positive,26881-27199,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,,,
ERR459755,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR459755_AMRSEG0002,NODE_1_length_921161_cov_27.299725,positive,491034-494449,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,,,
ERR459755,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR459755_AMRSEG0003,NODE_1_length_921161_cov_27.299725,positive,768439-769125,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,,,
ERR459757,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR459757_AMRSEG0001,NODE_2_length_525478_cov_23.023690,positive,95345-98760,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459757,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR459757_AMRSEG0002,NODE_2_length_525478_cov_23.023690,positive,372756-373442,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459757,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR459757_AMRSEG0003,NODE_8_length_276392_cov_22.191945,positive,26881-27199,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459840,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR459840_AMRSEG0001,NODE_2_length_1053344_cov_33.590042,positive,488575-491990,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,37.0,,
ERR459840,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR459840_AMRSEG0002,NODE_2_length_1053344_cov_33.590042,positive,764429-765115,100.0,85.3,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,37.0,,
ERR459840,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR459840_AMRSEG0003,NODE_6_length_307937_cov_32.847087,positive,54309-54627,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,37.0,,
ERR459841,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR459841_AMRSEG0001,NODE_3_length_525469_cov_30.546256,negative,152035-152721,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459841,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR459841_AMRSEG0002,NODE_3_length_525469_cov_30.546256,negative,426710-430125,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459841,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR459841_AMRSEG0003,NODE_7_length_303817_cov_29.674009,positive,54290-54608,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,440.0,,
ERR459866,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR459866_AMRSEG0001,NODE_1_length_784971_cov_33.851702,negative,167247-167933,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,444.0,,
ERR459866,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR459866_AMRSEG0002,NODE_1_length_784971_cov_33.851702,negative,448356-451771,97.25,80.88,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,444.0,,
ERR459866,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR459866_AMRSEG0003,NODE_9_length_210822_cov_32.975702,negative,149583-149901,92.46,83.39,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,444.0,,
ERR459867,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR459867_AMRSEG0001,NODE_2_length_935879_cov_32.292210,negative,167247-167933,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,444.0,,
ERR459867,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR459867_AMRSEG0002,NODE_2_length_935879_cov_32.292210,negative,448356-451771,97.25,80.88,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,444.0,,
ERR459867,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR459867_AMRSEG0003,NODE_4_length_634343_cov_30.698903,positive,60922-61240,92.46,83.39,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,444.0,,
ERR459975,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR459975_AMRSEG0001,NODE_2_length_1054843_cov_25.200737,positive,490074-493489,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,37.0,,
ERR459975,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR459975_AMRSEG0002,NODE_2_length_1054843_cov_25.200737,positive,765928-766614,100.0,85.3,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,37.0,,
ERR459975,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR459975_AMRSEG0003,NODE_6_length_295567_cov_25.647345,negative,240941-241259,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/3/18,37.0,,
ERR516496,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR516496_AMRSEG0001,NODE_1_length_1671874_cov_59.294147,negative,247299-247985,100.0,85.3,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/5/27,24.0,,
ERR516496,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR516496_AMRSEG0002,NODE_1_length_1671874_cov_59.294147,negative,539751-543166,97.25,80.77,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/5/27,24.0,,
ERR516496,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR516496_AMRSEG0003,NODE_2_length_1381433_cov_58.209191,positive,27114-27432,92.46,83.39,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/5/27,24.0,,
ERR516501,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,ERR516501_AMRSEG0001,NODE_1_length_1319116_cov_56.214421,positive,27114-27432,92.46,83.39,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/5/27,24.0,,
ERR516501,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",ERR516501_AMRSEG0002,NODE_4_length_625831_cov_56.549887,positive,82666-86081,97.25,80.77,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/5/27,24.0,,
ERR516501,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,ERR516501_AMRSEG0003,NODE_4_length_625831_cov_56.549887,positive,377847-378533,100.0,85.3,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,,2014/5/27,24.0,,
GCA_001854035.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCA_001854035.1_AMRSEG0001,MLIV01000006.1,negative,289820-290506,100.0,85.3,,,,,2016/10/26,37.0,,
GCA_001854035.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCA_001854035.1_AMRSEG0002,MLIV01000006.1,negative,562945-566360,97.25,80.74,,,,,2016/10/26,37.0,,
GCA_001854035.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCA_001854035.1_AMRSEG0003,MLIV01000103.1,positive,55899-56217,92.46,82.76,,,,,2016/10/26,37.0,,
GCA_002013615.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCA_002013615.1_AMRSEG0001,MAFG01000006.1,positive,300433-303848,97.25,80.74,,,,,2017/3/3,,,
GCA_002013615.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCA_002013615.1_AMRSEG0002,MAFG01000007.1,positive,97040-97726,100.0,85.3,,,,,2017/3/3,,,
GCF_001853535.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853535.1_AMRSEG0001,NZ_MLHZ01000010.1,positive,55899-56217,92.46,82.76,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :ovary,United States of America,2016/10/26,37.0,,
GCF_001853535.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853535.1_AMRSEG0002,NZ_MLHZ01000012.1,negative,237176-237862,100.0,85.3,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :ovary,United States of America,2016/10/26,37.0,,
GCF_001853535.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853535.1_AMRSEG0003,NZ_MLHZ01000012.1,negative,510301-513716,97.25,80.74,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :ovary,United States of America,2016/10/26,37.0,,
GCF_001853545.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853545.1_AMRSEG0001,NZ_MLHW01000001.1,positive,55899-56217,92.46,82.76,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :skeletal muscle,United States of America,2016/10/26,37.0,,
GCF_001853545.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853545.1_AMRSEG0002,NZ_MLHW01000009.1,negative,237176-237862,100.0,85.3,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :skeletal muscle,United States of America,2016/10/26,37.0,,
GCF_001853545.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853545.1_AMRSEG0003,NZ_MLHW01000009.1,negative,510301-513716,97.25,80.74,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :skeletal muscle,United States of America,2016/10/26,37.0,,
GCF_001853585.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853585.1_AMRSEG0001,NZ_MLII01000028.1,positive,27274-27592,92.46,83.39,,,,United States of America,2016/10/26,24.0,,
GCF_001853585.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853585.1_AMRSEG0002,NZ_MLII01000056.1,negative,131341-132027,100.0,85.3,,,,United States of America,2016/10/26,24.0,,
GCF_001853585.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853585.1_AMRSEG0003,NZ_MLII01000056.1,negative,426000-429415,97.25,80.77,,,,United States of America,2016/10/26,24.0,,
GCF_001853605.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853605.1_AMRSEG0001,NZ_MLHX01000023.1,positive,71607-75022,97.25,80.74,Animal,Homo sapiens,Animal:tail,United States of America,2016/10/26,37.0,,
GCF_001853605.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853605.1_AMRSEG0002,NZ_MLHX01000023.1,positive,347461-348147,100.0,85.3,Animal,Homo sapiens,Animal:tail,United States of America,2016/10/26,37.0,,
GCF_001853605.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853605.1_AMRSEG0003,NZ_MLHX01000028.1,negative,581885-582203,92.46,82.76,Animal,Homo sapiens,Animal:tail,United States of America,2016/10/26,37.0,,
GCF_001853615.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853615.1_AMRSEG0001,NZ_MLHY01000004.1,negative,237177-237863,100.0,85.3,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :ovary,United States of America,2016/10/26,37.0,,
GCF_001853615.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853615.1_AMRSEG0002,NZ_MLHY01000004.1,negative,510302-513717,97.25,80.74,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :ovary,United States of America,2016/10/26,37.0,,
GCF_001853615.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853615.1_AMRSEG0003,NZ_MLHY01000014.1,positive,55899-56217,92.46,82.76,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :ovary,United States of America,2016/10/26,37.0,,
GCF_001853665.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853665.1_AMRSEG0001,NZ_MLIG01000006.1,positive,55899-56217,92.46,82.76,Environment,Environment: urban environment,Environment:Urban environment:aquarium,United States of America,2016/10/26,37.0,,
GCF_001853665.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853665.1_AMRSEG0002,NZ_MLIG01000016.1,negative,289820-290506,100.0,85.3,Environment,Environment: urban environment,Environment:Urban environment:aquarium,United States of America,2016/10/26,37.0,,
GCF_001853665.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853665.1_AMRSEG0003,NZ_MLIG01000016.1,negative,562945-566360,97.25,80.74,Environment,Environment: urban environment,Environment:Urban environment:aquarium,United States of America,2016/10/26,37.0,,
GCF_001853685.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853685.1_AMRSEG0001,NZ_MLIE01000015.1,positive,447033-450448,97.28,80.58,,,,United States of America,2016/10/26,466.0,,
GCF_001853685.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853685.1_AMRSEG0002,NZ_MLIE01000015.1,positive,723885-724571,100.0,85.01,,,,United States of America,2016/10/26,466.0,,
GCF_001853685.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853685.1_AMRSEG0003,NZ_MLIE01000016.1,negative,1437508-1437826,92.46,83.07,,,,United States of America,2016/10/26,466.0,,
GCF_001853695.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853695.1_AMRSEG0001,NZ_MLID01000011.1,negative,237938-238624,100.0,85.59,,,,United States of America,2016/10/26,453.0,,
GCF_001853695.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853695.1_AMRSEG0002,NZ_MLID01000011.1,negative,513664-517079,97.25,80.91,,,,United States of America,2016/10/26,453.0,,
GCF_001853695.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853695.1_AMRSEG0003,NZ_MLID01000020.1,negative,512313-512631,92.46,83.39,,,,United States of America,2016/10/26,453.0,,
GCF_001853715.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853715.1_AMRSEG0001,NZ_MLIB01000022.1,positive,447033-450448,97.28,80.58,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :liver and mesentery,United States of America,2016/10/26,466.0,,
GCF_001853715.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853715.1_AMRSEG0002,NZ_MLIB01000022.1,positive,723885-724571,100.0,85.01,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :liver and mesentery,United States of America,2016/10/26,466.0,,
GCF_001853715.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853715.1_AMRSEG0003,NZ_MLIB01000023.1,negative,1490136-1490454,92.46,83.07,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :liver and mesentery,United States of America,2016/10/26,466.0,,
GCF_001853745.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853745.1_AMRSEG0001,NZ_MLIA01000009.1,positive,61005-61323,92.46,83.07,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue,United States of America,2016/10/26,466.0,,
GCF_001853745.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853745.1_AMRSEG0002,NZ_MLIA01000011.1,positive,446363-449778,97.28,80.58,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue,United States of America,2016/10/26,466.0,,
GCF_001853745.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853745.1_AMRSEG0003,NZ_MLIA01000011.1,positive,723215-723901,100.0,85.01,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue,United States of America,2016/10/26,466.0,,
GCF_001853775.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853775.1_AMRSEG0001,NZ_MLIF01000015.1,negative,289820-290506,100.0,85.3,Environment,Environment: urban environment,Environment:Urban environment:aquarium,United States of America,2016/10/26,37.0,,
GCF_001853775.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853775.1_AMRSEG0002,NZ_MLIF01000015.1,negative,562940-566355,97.25,80.74,Environment,Environment: urban environment,Environment:Urban environment:aquarium,United States of America,2016/10/26,37.0,,
GCF_001853775.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853775.1_AMRSEG0003,NZ_MLIF01000015.1,negative,3790088-3790406,92.46,82.76,Environment,Environment: urban environment,Environment:Urban environment:aquarium,United States of America,2016/10/26,37.0,,
GCF_001853805.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853805.1_AMRSEG0001,NZ_MLIJ01000016.1,negative,258209-258895,100.0,85.44,Homo sapiens,Homo sapiens: pulmonary,Homo sapiens:pulmonary :sputum,United States of America,2016/10/26,444.0,,
GCF_001853805.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853805.1_AMRSEG0002,NZ_MLIJ01000016.1,negative,538953-542368,97.25,80.88,Homo sapiens,Homo sapiens: pulmonary,Homo sapiens:pulmonary :sputum,United States of America,2016/10/26,444.0,,
GCF_001853805.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853805.1_AMRSEG0003,NZ_MLIJ01000019.1,positive,60986-61304,92.46,83.39,Homo sapiens,Homo sapiens: pulmonary,Homo sapiens:pulmonary :sputum,United States of America,2016/10/26,444.0,,
GCF_001853845.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853845.1_AMRSEG0001,NZ_MLIL01000002.1,positive,182297-182615,92.46,83.07,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (calf),United States of America,2016/10/26,438.0,,
GCF_001853845.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853845.1_AMRSEG0002,NZ_MLIL01000002.1,positive,3372409-3375824,97.25,80.74,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (calf),United States of America,2016/10/26,438.0,,
GCF_001853845.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853845.1_AMRSEG0003,NZ_MLIL01000002.1,positive,3655580-3656266,100.0,85.44,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (calf),United States of America,2016/10/26,438.0,,
GCF_001853865.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853865.1_AMRSEG0001,NZ_MLIM01000023.1,negative,90594-91280,100.0,85.44,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (foot),United States of America,2016/10/26,439.0,,
GCF_001853865.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853865.1_AMRSEG0002,NZ_MLIM01000023.1,negative,365136-368551,97.33,81.01,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (foot),United States of America,2016/10/26,439.0,,
GCF_001853865.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853865.1_AMRSEG0003,NZ_MLIM01000066.1,positive,61720-62038,92.46,83.39,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (foot),United States of America,2016/10/26,439.0,,
GCF_001853885.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853885.1_AMRSEG0001,NZ_MLIO01000012.1,negative,118168-118854,100.0,85.15,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (axilla),United States of America,2016/10/26,440.0,,
GCF_001853885.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853885.1_AMRSEG0002,NZ_MLIO01000012.1,negative,390569-393984,97.25,80.74,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (axilla),United States of America,2016/10/26,440.0,,
GCF_001853885.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853885.1_AMRSEG0003,NZ_MLIO01000015.1,negative,1496200-1496518,92.46,83.07,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (axilla),United States of America,2016/10/26,440.0,,
GCF_001853895.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853895.1_AMRSEG0001,NZ_MLIT01000006.1,positive,193698-194016,92.46,83.39,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (skin),United States of America,2016/10/26,443.0,,
GCF_001853895.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853895.1_AMRSEG0002,NZ_MLIT01000014.1,positive,509890-513305,97.25,80.77,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (skin),United States of America,2016/10/26,443.0,,
GCF_001853895.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853895.1_AMRSEG0003,NZ_MLIT01000014.1,positive,789182-789868,100.0,85.3,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (skin),United States of America,2016/10/26,443.0,,
GCF_001853925.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853925.1_AMRSEG0001,NZ_MLIN01000002.1,positive,54335-54653,92.46,83.07,Homo sapiens,Homo sapiens: pulmonary,Homo sapiens:pulmonary :sputum,United States of America,2016/10/26,37.0,,
GCF_001853925.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853925.1_AMRSEG0002,NZ_MLIN01000016.1,positive,45548-48963,97.25,80.71,Homo sapiens,Homo sapiens: pulmonary,Homo sapiens:pulmonary :sputum,United States of America,2016/10/26,37.0,,
GCF_001853925.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853925.1_AMRSEG0003,NZ_MLIN01000016.1,positive,320799-321485,100.0,85.3,Homo sapiens,Homo sapiens: pulmonary,Homo sapiens:pulmonary :sputum,United States of America,2016/10/26,37.0,,
GCF_001853945.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853945.1_AMRSEG0001,NZ_MLIQ01000011.1,positive,27268-27586,92.46,83.39,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :knee (synovial fluid),United States of America,2016/10/26,24.0,,
GCF_001853945.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853945.1_AMRSEG0002,NZ_MLIQ01000023.1,positive,82730-86145,97.25,80.77,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :knee (synovial fluid),United States of America,2016/10/26,24.0,,
GCF_001853945.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853945.1_AMRSEG0003,NZ_MLIQ01000023.1,positive,377879-378565,100.0,85.3,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :knee (synovial fluid),United States of America,2016/10/26,24.0,,
GCF_001853965.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853965.1_AMRSEG0001,NZ_MLIP01000001.1,positive,54459-54777,92.46,82.76,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :eye,United States of America,2016/10/26,37.0,,
GCF_001853965.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853965.1_AMRSEG0002,NZ_MLIP01000004.1,negative,286681-287367,100.0,85.44,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :eye,United States of America,2016/10/26,37.0,,
GCF_001853965.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853965.1_AMRSEG0003,NZ_MLIP01000004.1,negative,563247-566662,97.25,80.77,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :eye,United States of America,2016/10/26,37.0,,
GCF_001853985.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853985.1_AMRSEG0001,NZ_MLIR01000002.1,negative,42459-43145,100.0,85.44,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (finger),United States of America,2016/10/26,441.0,,
GCF_001853985.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853985.1_AMRSEG0002,NZ_MLIR01000002.1,negative,321353-324768,97.25,80.88,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (finger),United States of America,2016/10/26,441.0,,
GCF_001853985.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853985.1_AMRSEG0003,NZ_MLIR01000012.1,positive,62851-63169,92.46,82.76,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (finger),United States of America,2016/10/26,441.0,,
GCF_001853995.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001853995.1_AMRSEG0001,NZ_MLIS01000001.1,positive,201699-202017,92.46,83.07,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (leg),United States of America,2016/10/26,442.0,,
GCF_001853995.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001853995.1_AMRSEG0002,NZ_MLIS01000001.1,positive,3506675-3510090,97.25,80.77,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (leg),United States of America,2016/10/26,442.0,,
GCF_001853995.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001853995.1_AMRSEG0003,NZ_MLIS01000001.1,positive,3802853-3803539,100.0,85.3,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (leg),United States of America,2016/10/26,442.0,,
GCF_001854015.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001854015.1_AMRSEG0001,NZ_MLIU01000028.1,negative,327491-328177,100.0,85.3,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (leg),United States of America,2016/10/26,24.0,,
GCF_001854015.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001854015.1_AMRSEG0002,NZ_MLIU01000028.1,negative,619942-623357,97.25,80.77,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (leg),United States of America,2016/10/26,24.0,,
GCF_001854015.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001854015.1_AMRSEG0003,NZ_MLIU01000028.1,negative,3755425-3755743,92.46,83.39,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extrapulmonary :soft tissue (leg),United States of America,2016/10/26,24.0,,
GCF_015700725.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_015700725.1_AMRSEG0001,NZ_JAAOOR010000001.1,positive,910975-911293,92.46,83.07,,,,,2020/11/30,,,
GCF_015700725.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_015700725.1_AMRSEG0002,NZ_JAAOOR010000001.1,positive,4146891-4150306,97.28,80.58,,,,,2020/11/30,,,
GCF_015700725.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_015700725.1_AMRSEG0003,NZ_JAAOOR010000001.1,positive,4423735-4424421,100.0,85.01,,,,,2020/11/30,,,
GCF_015700775.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_015700775.1_AMRSEG0001,NZ_JAAOOS010000001.1,negative,1983432-1983750,92.46,82.76,,,,,2020/11/30,441.0,,
GCF_015700775.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_015700775.1_AMRSEG0002,NZ_JAAOOS010000002.1,negative,664958-665644,100.0,85.44,,,,,2020/11/30,441.0,,
GCF_015700775.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_015700775.1_AMRSEG0003,NZ_JAAOOS010000002.1,negative,943852-947267,97.25,80.85,,,,,2020/11/30,441.0,,
GCF_015700795.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_015700795.1_AMRSEG0001,NZ_JAAOOT010000001.1,positive,230990-234405,97.25,80.74,,,,,2020/11/30,440.0,,
GCF_015700795.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_015700795.1_AMRSEG0002,NZ_JAAOOT010000007.1,positive,22396-22714,92.46,83.07,,,,,2020/11/30,440.0,,
GCF_015700795.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_015700795.1_AMRSEG0003,NZ_JAAOOT010000012.1,negative,33078-33764,100.0,85.15,,,,,2020/11/30,440.0,,
GCF_016767715.1,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_016767715.1_AMRSEG0001,NZ_CP050145.1,negative,2237495-2237813,92.46,83.07,,,,,2021/1/28,442.0,,
GCF_016767715.1,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_016767715.1_AMRSEG0002,NZ_CP050145.1,negative,3696575-3697261,100.0,85.3,,,,,2021/1/28,442.0,,
GCF_016767715.1,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_016767715.1_AMRSEG0003,NZ_CP050145.1,negative,3990024-3993439,97.25,80.77,,,,,2021/1/28,442.0,,
SRR3617047,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR3617047_AMRSEG0001,NODE_13_length_134973_cov_25.049952,positive,108216-108902,100.0,85.3,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extraplumonary:Foot,Belgium,2017/1/1,704.0,,
SRR3617047,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR3617047_AMRSEG0002,NODE_22_length_75259_cov_24.608875,positive,21702-22020,92.46,83.07,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extraplumonary:Foot,Belgium,2017/1/1,704.0,,
SRR3617047,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR3617047_AMRSEG0003,NODE_2_length_694029_cov_25.318020,positive,505538-508953,97.25,80.77,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extraplumonary:Foot,Belgium,2017/1/1,704.0,,
SRR3617048,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR3617048_AMRSEG0001,NODE_4_length_337892_cov_30.785276,negative,103419-106834,97.25,80.77,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extraplumonary:Tissue from hand,Belgium,2017/1/1,37.0,,
SRR3617048,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR3617048_AMRSEG0002,NODE_7_length_250694_cov_29.308453,positive,54289-54607,92.46,82.76,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extraplumonary:Tissue from hand,Belgium,2017/1/1,37.0,,
SRR3617048,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR3617048_AMRSEG0003,NODE_9_length_208847_cov_30.237648,positive,108269-108955,100.0,85.44,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extraplumonary:Tissue from hand,Belgium,2017/1/1,37.0,,
SRR3617050,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR3617050_AMRSEG0001,NODE_3_length_469254_cov_30.031753,positive,22447-22765,92.46,82.76,Environment,Environment: urban environment,Environment:Urban enviroment:Tap water,Germany,2017/1/1,37.0,,
SRR3617050,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR3617050_AMRSEG0002,NODE_6_length_336964_cov_31.131398,negative,102502-105917,97.25,80.74,Environment,Environment: urban environment,Environment:Urban enviroment:Tap water,Germany,2017/1/1,37.0,,
SRR3617050,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR3617050_AMRSEG0003,NODE_8_length_234711_cov_30.362709,positive,108269-108955,100.0,85.3,Environment,Environment: urban environment,Environment:Urban enviroment:Tap water,Germany,2017/1/1,37.0,,
SRR3617055,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR3617055_AMRSEG0001,NODE_4_length_398623_cov_37.840122,negative,164163-167578,97.25,80.74,Environment,Environment: urban environment,Environment:Urban enviroment:Tap water,Germany,2017/1/1,37.0,,
SRR3617055,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR3617055_AMRSEG0002,NODE_5_length_397223_cov_38.680517,negative,288230-288916,100.0,85.3,Environment,Environment: urban environment,Environment:Urban enviroment:Tap water,Germany,2017/1/1,37.0,,
SRR3617055,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR3617055_AMRSEG0003,NODE_7_length_315245_cov_37.927048,negative,260619-260937,92.46,82.76,Environment,Environment: urban environment,Environment:Urban enviroment:Tap water,Germany,2017/1/1,37.0,,
SRR3617056,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR3617056_AMRSEG0001,NODE_2_length_398651_cov_29.667863,negative,164166-167581,97.25,80.74,Environment,Environment: urban environment,Environment:Urban enviroment:Tap water,Germany,2017/1/1,37.0,,
SRR3617056,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR3617056_AMRSEG0002,NODE_6_length_283384_cov_26.769685,negative,260620-260938,92.46,82.76,Environment,Environment: urban environment,Environment:Urban enviroment:Tap water,Germany,2017/1/1,37.0,,
SRR6046331,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR6046331_AMRSEG0001,NODE_13_length_142011_cov_29.624454,positive,108251-108937,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,440.0,,
SRR6046331,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR6046331_AMRSEG0002,NODE_2_length_336977_cov_33.170498,positive,231082-234497,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,440.0,,
SRR6046331,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR6046331_AMRSEG0003,NODE_7_length_210919_cov_29.308552,positive,22445-22763,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,440.0,,
SRR6046352,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR6046352_AMRSEG0001,NODE_24_length_84082_cov_21.194147,negative,33077-33763,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,440.0,,
SRR6046352,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR6046352_AMRSEG0002,NODE_5_length_210957_cov_22.323608,negative,102443-105858,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,440.0,,
SRR6046352,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR6046352_AMRSEG0003,NODE_6_length_210922_cov_20.325682,positive,22448-22766,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,440.0,,
SRR6046404,chelonae,1774,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR6046404_AMRSEG0001,NODE_24_length_84055_cov_20.752679,negative,33087-33773,100.0,85.44,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,440.0,,
SRR6046404,chelonae,1774,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR6046404_AMRSEG0002,NODE_25_length_83024_cov_19.713624,positive,22448-22766,92.46,82.76,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,440.0,,
SRR6046404,chelonae,1774,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR6046404_AMRSEG0003,NODE_7_length_210631_cov_22.059738,negative,102502-105917,97.25,80.74,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,440.0,,